Clinical Trial Update: Optical Coherence Tomography for EVERolimus Eluting STent [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating optical coherence tomography in relation to an everolimus-eluting stent for coronary artery disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: A.O. Ospedale Papa Giovanni XXIII | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED